A Clinical Study to Evaluate Single-agent Therapy of BR113 for Injection in Patients With Advanced Solid Tumors

NCT07753590 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

258

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: BR113 for injection

Sponsor

BioRay Pharmaceutical Co., Ltd.